ReviewBiomedicines2024

Efficacy and Safety of Atezolizumab as a PD-L1 Inhibitor in the Treatment of Cervical Cancer: A Systematic Review.

Milan Daniel Velimirovici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.